A-16 RFP: a Novel Biomarker for Cancer
ΓùÅ Effective: This agent will assist the effectiveness of known anti-cancer drugsΓùÅ Safe: Combination use of this agent will reduce the amount of anti-cancer drugsΓùÅ Assistance: This agent will assist the decisions for treatment method
ΓùÅ Therapeutic antibody drug for cancer patientsΓùÅ Gene/Protein Biomarker for cancer prognosisΓùÅ Anti-RFP antibody can be used as a research tool for lab technicians
None
Patent Number: WO2010023917A1
Application Number: WO2009JP4162A
Inventor: TAKAHASHI, Masahide | KATO, Takuya | KIKKAWA, Fumitaka
Priority Date: 1 Sep 2008
Priority Number: WO2010023917A1
Application Date: 27 Aug 2009
Publication Date: 4 Mar 2010
IPC Current: A61K004500 | A61K00317105 | A61K0031711 | A61K0031713 | A61K003843 | A61K004506 | A61K004800 | A61P003500 | A61P003502 | A61P004300 | C12N001509 | C12Q000168 | G01N003348 | G01N003353
Assignee Applicant: National University Corporation Nagoya University
Title: POTENTIATOR OF ACTIVITY OF ANTI-CANCER AGENT AND USE THEREOF, AND BIOMARKER FOR PREDICTION OF PROGNOSIS IN CANCER PATIENT AND USE THEREOF | POTENTIALISATEUR DE L'ACTIVITÉ D'UN AGENT ANTICANCÉREUX ET SON UTILISATION, ET BIOMARQUEUR PERMETTANT D'ÉMETTRE UN
Usefulness: POTENTIATOR OF ACTIVITY OF ANTI-CANCER AGENT AND USE THEREOF, AND BIOMARKER FOR PREDICTION OF PROGNOSIS IN CANCER PATIENT AND USE THEREOF | POTENTIALISATEUR DE L'ACTIVITÉ D'UN AGENT ANTICANCÉREUX ET SON UTILISATION, ET BIOMARQUEUR PERMETTANT D'ÉMETTRE UN PRONOSTIC CONCERNANT UN PATIENT CANCÉREUX ET SON UTILISATION
Summary: The potentiator is useful for enhancing activity of agent for treating cancer, e.g. colon cancer and endometrial cancer (all claimed) in mammal e.g. mouse, rat, cow, pig, cat and human.
Novelty: Activity potentiator of agent for treating cancer, e.g. colon cancer and endometrial cancer, comprises compound capable of inhibiting expression of RET finger protein gene or its activity as active ingredient
診斷/治療
癌症/腫瘤
美國
